The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.

The active ingredient in Wegovy is semaglutide, which is likely to go off-patent in 2026 in India. Wegovy and Lilly’s Mounjaro belong to the same class of treatments called GLP-1 agonists ...

Although it's been something of an up-and-down stock so far this year, Novo Nordisk remains the pacesetter in the market for GLP-1 drugs, of which Wegovy -- indicated specifically for weight loss ...

Novo Nordisk’s team in India is urging the global leadership to launch its drug Wegovy as early as 2025 in India, a year ahead of the company’s original target. While Wegovy has already been ...

Novo Nordisk’s team in India is urging the global leadership to launch its drug Wegovy as early as 2025 in India, a year ahead of the company’s original target. While Wegovy has already been approved ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...

Loreen's UK and Ireland 2025 tour setlist in full ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

Our ongoing 12-week study in Australia is well positioned to further ... both an oral (Rybelsus®) and an injectable (Ozempic® and Wegovy®). This research yielded similar findings wherein ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

TME UNI Chart, provided by Tencent Music Entertainment Group, ranks the top songs within China based on streaming and sales activity from seven major platforms (QQ Music, Kugou Music, Kuwo Music ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...